Tell the clinician about your anabolic steroid use: what you used, how you took it, when you started or stopped, what else you took and what has changed. Say when an ingredient or amount is uncertain. You can ask for a health assessment, help with symptoms or support with stopping without arriving with a diagnosis.
If you have severe breathing difficulty, chest pain with breathlessness, new stroke symptoms or an immediate risk of serious self harm, seek emergency help now. Do not wait to prepare an appointment note.
A useful way to start the conversation
A simple opening is enough: “I have used anabolic steroids outside medical care. I want help checking my health and discussing these symptoms.” If you have already stopped, say when. If you are still using, say that too. You do not need to promise an outcome before explaining the concern that brought you to the appointment.
Choose the issue you most want addressed today: a physical symptom, a worrying result, sleep or mood, sexual function, fertility, or difficulty stopping. You can add: “My main concern today is ___, and it began ___.” Written notes can help you remember details; the NHS appointment checklist also suggests bringing medicines and asking for explanations in plain language.
| Your concern | A possible opening | Useful detail to add |
|---|---|---|
| Symptoms during anabolic steroid use | “I want these symptoms assessed.” | What changed, when it began and the products used. |
| Symptoms after stopping anabolic steroids | “I stopped recently and have felt different since.” | The stopping date and changes in mood, sleep or sexual function. |
| Anabolic steroid use and a test result | “Can we discuss what this result means for me?” | The full report, prior results and recent exposure. |
| Privacy before discussing steroid use | “Can you explain how my information will be used?” | The particular record or disclosure you are concerned about. |
When an appointment should not wait
Suicidal thoughts without an immediate plan still deserve support now. Contact a crisis service and seek urgent mental health assessment instead of waiting for a routine visit. The NHS urgent mental health advice separates crisis support from an emergency response.
- UK: call Samaritans on 116 123.
- USA: call or text 988.
- Canada: call or text 988.
- Australia: call Lifeline on 13 11 14.
New jaundice needs prompt medical review; jaundice with sudden fever, confusion or intense abdominal pain needs emergency help. A painful, hot or swollen injection site needs urgent assessment, especially with fever. Healthdirect’s jaundice advice and NHS skin infection advice describe these problems. Tell the service what is happening when you make contact so it can assess urgency.
If fear of judgment makes disclosure difficult
Concerns about judgment are documented in research. A 2015 study of 148 healthcare providers randomly assigned fictional patient descriptions and asked providers to rate their attitudes. The descriptions of men using anabolic steroids received less favourable ratings than some comparison descriptions. This measured reactions to vignettes, not the quality of real appointments or how every clinician behaves.
A 2022 review of physician support seeking combined 36 studies involving 10,101 anabolic steroid users. Its pooled estimate was about 37%, with large differences between populations and settings. It does not show that most doctors refuse care, and it is not a current rate for your local service. Barriers can include expectations of poor care, stigma and practical access difficulties.
You can name the difficulty directly: “I am worried about being judged, which has made this hard to bring up.” Then return to the health question. If saying it aloud feels difficult, hand over a short note. The aim is to give the clinician information needed to assess you, including uncertainties, rather than to defend or minimise the use.
Prepare a use and symptom history
Bring what you know, even if the record is incomplete. A dated note is more useful than trying to remember every detail under pressure. Separate confirmed information from what a seller or another person told you. The clinician can work with “unknown” more accurately than an assumed ingredient or an invented amount.
- Products and forms: names on labels, informal names, tablets, injections, gels, creams or other forms. Note any change of product or source.
- Exposure: approximate start and stop dates, the amounts you believe you took, frequency and the last use. Say if measuring or labelling was uncertain.
- Other substances: prescriptions, pharmacy medicines, vitamins, supplements, stimulants, alcohol, nicotine, recreational drugs and other hormones or recovery products.
- Symptoms: what changed, when it started, severity, pattern and effects on daily life. Include sleep, appetite, energy, mood and sexual changes.
- Health history: previous heart, blood pressure, liver, kidney, hormone, fertility or mental health problems, and relevant family history.
- Injection or blood exposure: reused or shared equipment, contact with another person’s blood, injection injuries and any pain, swelling, redness or fever.
- Previous care: full laboratory reports, emergency visits, specialist letters and medicines previously suggested, including any adverse effects.
- Your priorities: symptom relief, stopping, fertility, mental health, concerns about dependence, or a plan for monitoring and followup.
The NSW clinical resource on performance and image enhancing drugs supports taking a broad exposure and health history. A photograph of packaging can help identify what was claimed, but it cannot prove the contents. Analysis of illicit anabolic products has found substituted, missing and incorrectly labelled ingredients; the 2022 product analysis review documents that uncertainty.
If a possible HIV exposure happened recently through shared equipment or another blood exposure, ask for urgent assessment. Medicines used after a possible exposure must be started within 72 hours, and sooner is better; not every exposure requires them. Do not wait for this appointment checklist or for symptoms. CDC advice on HIV care after exposure explains the time window.
What a clinician may ask and why
Questions about training, body image, sleep, relationships, sexual function and mood can be relevant to treatment. Anabolic steroids can suppress signals between the brain and reproductive organs. Symptoms after stopping can overlap with other medical or mental health problems, so a clinician needs more than a testosterone result to interpret them. Anawalt’s clinical review describes assessment of anabolic steroid use.
Tell the clinician about low mood, fatigue, reduced libido, sleep changes or cravings after stopping, including similar episodes in the past. A 2022 review of use and cessation symptoms describes a variable symptom range and limits in the available research. A symptom beginning after a change in use is relevant, but timing alone does not prove the cause.
You may be asked about repeated attempts to stop, use despite harm, loss of control or reliance on the drug to cope with changes in appearance. These questions help assess dependence and support needs. Dependence can occur without a typical intoxicating high. The MedlinePlus anabolic steroid summary explains this distinction.
Tell the clinician privately if someone controls your medicines, pressures you to use, threatens you or makes it unsafe to speak openly. You can ask for part of the appointment alone. A supporter can help with notes, but should not prevent you from explaining your own symptoms and wishes.
What the assessment may include
A clinician may check blood pressure, pulse and other physical findings, and choose tests based on symptoms, exposure and medical history. Blood count, lipids, liver and kidney measures, glucose and selected hormone tests may answer different questions. An electrocardiogram, imaging or specialist assessment may be appropriate for particular symptoms or findings; they are not automatic tests for everyone who has used steroids.
The 2026 Australian primary care review describes this clinical approach. Hormone results during ongoing use cannot by themselves establish recovery. Fertility concerns can require semen assessment and a reproductive pathway, rather than assuming that a blood testosterone result answers the question.
Tell the clinician about recent hard training, supplements and the timing of the last exposure before interpreting results. Creatinine can be influenced by muscle mass, creatine and exercise, so an isolated result needs context. The National Kidney Foundation’s creatinine explanation covers these influences. Do not alter prescribed medicines or manipulate your routine to produce a more reassuring result.
Normal blood tests do not exclude every cardiac, psychiatric, infectious or reproductive problem. Ask which question each proposed test answers, what it cannot show and what would change the care plan. The blood test article explains common tests and their limits. A clinician may need previous results, a repeat sample or a different investigation.
Confidentiality and the medical record
Start with the specific concern: “Who can see this information, and when might you need to share it?” Ask how the service records substance use, communicates results and handles appointment reminders. If a shared phone, online account or family contact creates a problem, say so and ask what communication options are available.
As a UK example, General Medical Council confidentiality standards recognise a duty of confidentiality alongside circumstances for sharing, including consent, legal requirements and justified public interest disclosures. The details depend on the situation. This is not a guarantee about every country, age group or service. Ask the clinician to explain the rules that apply to your care.
If insurance, employment, military service or organised sport is the concern, ask which records or reports may be requested and who can explain that process. Medical care and sport reporting requirements are separate issues to clarify with the relevant service or qualified adviser. Do not assume a clinic’s confidentiality explanation answers every external reporting question.
Younger patients can ask about private consultation time, parental involvement and the limits of confidentiality before sharing details. If involving a parent or supporter would make you unsafe, tell the clinician. Ask for an age appropriate explanation of how the service handles safety concerns.
If you want to stop, or are not ready yet
Say what you want help with now. “I want to stop, but I am worried about my mood and sexual symptoms” gives a different starting point from “I am still using and need this symptom assessed.” Physical care, mental health support and discussion of future use can begin in the same visit.
The research on specific treatments for anabolic steroid cessation remains limited. A 2019 scoping review of treatments found much of the literature consisted of case reports, with little research on interventions for stopping and dependence. That does not mean depression, hormonal problems or other complications should go untreated. Treatment decisions depend on the person and the condition being assessed.
Do not borrow another person’s prescription or copy an online hormone recovery schedule. Tell the clinician about any recovery medicines already taken. Discuss prior withdrawal, plans for conception and current mood before deciding the next step. Referral may involve endocrinology, fertility care, mental health or substance use treatment, with other specialties involved for physical complications.
If the conversation is difficult or care is hard to reach
You can ask for a clear clinical response: “I hear your recommendation to stop. I also need these symptoms assessed and a plan for what happens next.” Ask what a test or referral would change and what alternatives are available. If a request is declined, ask for the reason and the next suitable route.
If communication remains poor, consider another licensed clinician or ask about a service with experience in performance drug concerns. Ask your primary care service about appropriate endocrine, sexual health, mental health or substance use referrals. A difficult encounter does not remove the need to assess a worsening symptom.
When booking, ask about cost, access, a longer appointment if needed, an interpreter or another communication aid. You can bring a trusted person if you want support and still request time alone. If travel or privacy makes a remote appointment attractive, ask if an examination is needed and where any tests would be arranged.
Leave with a clear next step
Before the appointment ends, check the plan in your own words: “My next step is ___, the results will come from ___, and I should seek earlier help if ___.” Ask for unfamiliar terms to be explained. A written plan can make it easier to follow through after a stressful conversation.
- Which concern is being assessed first, and what other causes are being considered?
- Which tests would change care, and what preparation or timing is needed?
- Who will review the results, when should I expect them and whom should I contact if they do not arrive?
- Which medicine interactions or symptoms need earlier review?
- Who is arranging the referral, and what should I do while waiting?
- When is the next appointment, and what changes in use or symptoms should I report before then?
Keep your notes and the full results, arrange the agreed followup and contact the service if the plan does not arrive. Report new symptoms or changes in use rather than assuming the earlier assessment still answers them. For official crisis and treatment contacts in the UK, USA, Canada and Australia, use medical and treatment support.